ArticleMedicine2025
Genetic determinants of micronutrient levels and their causal impact on osteonecrosis of the femoral head: A 2-sample Mendelian randomization study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteonecrosis of the femoral head (ONFH) is a debilitating condition with unclear pathophysiology. Micronutrients are implicated in bone health, but their causal relationship with ONFH remains uncertain. This study aims to investigate the potential causal relationship between circulating levels of 15 micronutrients and the risk of ONFH using a 2-sample Mendelian randomization (MR) approach. The objective was to determine whether circulating levels of specific micronutrients (copper, calcium, carotene, folate, iron, magnesium, potassium, selenium, vitamin A, vitamin B12, vitamin B6, vitamin C, vitamin D, vitamin E, and zinc) have a causal impact on the risk of ONFH. This study employed a 2-sample MR approach using summary-level data from 15 genome-wide association studies (GWAS) focused on micronutrient exposures and 1 GWAS for ONFH. The study adhered to 3 fundamental MR assumptions and used the inverse variance weighting method as the primary analysis method, supplemented by MR-Egger regression and MR-PRESSO to assess heterogeneity and pleiotropy. To minimize population stratification bias, the study included only individuals of European descent. The primary finding was a significant association between genetically predicted higher levels of potassium and a reduced risk of ONFH (OR = 0.440, 95% confidence interval (CI) 0.2012-0.959, P = .039 per 1 standard deviation). No other micronutrients showed significant associations with ONFH risk. Sensitivity analyses, including MR-Egger regression and leave-one-out analysis, confirmed the robustness of these findings. Our findings indicate a significant association between genetically predicted higher potassium levels and a reduced risk of ONFH in individuals of European descent, while no other micronutrients demonstrated significant associations. Sensitivity analyses confirmed these results, suggesting a potential protective role of potassium in ONFH.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.